Novan Inc (NOVN) – Strategy, SWOT and Corporate Finance Report

Novan Inc (NOVN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Novan Inc (Novan) is a clinical development-stage biotechnology company that focuses on leveraging nitric oxide’s immunomodulatory and anti-microbial mechanisms of action for the treatment of diseases with unmet needs. The company’s products find application in the treatment of dermatology disorders, gastroenterology and women’s health. Its pipeline products focus on treating acne vulgaris, external genital warts, onychomycosis, psoriasis, molluscum, tinea pedis, human papillomavirus (HPV) and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in collaboration with academic institutions, private and public companies and other universities. Novan is headquartered in Morrisville, North Carolina, the US.

Scope

• Detailed information on Novan Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Novan Inc in the form of a SWOT analysis

• An in-depth view of the business model of Novan Inc including a breakdown and examination of key business segments

• News about Novan Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Novan Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Novan Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Novan Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Vaxart Inc

Mycovia Pharmaceuticals Inc

Melinta Therapeutics Inc

ImmunoGen Inc

Helix BioMedix Inc

AnaptysBio Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Novan Inc - Key Facts

Novan Inc - Key Employees

Novan Inc - Key Employee Biographies

Novan Inc - Major Products and Services

Novan Inc - History

Novan Inc - Company Statement

Novan Inc - Locations And Subsidiaries

Head Office

Section 2 – Company Analysis

Company Overview

Novan Inc - Business Description

Business Segment: Government Research Contracts and Grants

Performance

Business Segment: License and collaboration

Performance

R&D Overview

Novan Inc - SWOT Analysis

SWOT Analysis - Overview

Novan Inc - Strengths

Novan Inc - Weaknesses

Novan Inc - Opportunities

Novan Inc - Threats

Novan Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

Novan Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 02, 2021: Novan bolsters commercialization expertise with election of Steven D. Skolsky to board of directors

Jan 19, 2021: Novan announces new corporate headquarters

Oct 30, 2020: Novan reports third quarter 2020 financial results and provides corporate update

Oct 14, 2020: Novan’s Nitricil technology shows in vitro antiviral effect against sars-cov-2 in human airway infection model

Sep 24, 2020: Novan strengthens financial leadership with appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors

Jul 28, 2020: Novan President and CEO, Paula Brown Stafford named Chairman of the Board

Apr 22, 2020: NOVAN announces paycheck protection program term note

Apr 20, 2020: Novan announces comprehensive evaluation of strategic and financial alternatives

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Novan Inc, Key Facts

Novan Inc, Key Employees

Novan Inc, Key Employee Biographies

Novan Inc, Major Products and Services

Novan Inc, History

Novan Inc, Key Competitors

Novan Inc, Ratios based on current share price

Novan Inc, Annual Ratios

Novan Inc, Annual Ratios (Cont…1)

Novan Inc, Interim Ratios

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

Novan Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Novan Inc, Performance Chart (2016 – 2020)

Novan Inc, Ratio Charts

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports